DalsnaFinance

Lupin Launches Azilsartan Medoxomil Tablets in the United States

Markets PR Newswire By PR Newswire 17 Jun 2026 15:56 1 min read
Lupin Launches Azilsartan Medoxomil Tablets in the United States

MUMBAI, India and Naples, Fla., June 17, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of Azilsartan Medoxomil Tablets, 40mg and 80mg in the United States following the...

MUMBAI, India and Naples, Fla., June 17, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of Azilsartan Medoxomil Tablets, 40mg and 80mg in the United States following the...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.